studyId: syn53604892 studyName: Advancing RAS pathway targeted therapy in NF1-MPNST - effects of SHP2 and CDK4 or CDK6 inhibitors on the tumor and the tumor immune microenvironment accessType: Private initiative: Other fundingAgency: Other
Drop files to upload
rna-seq-de-analysis-resistant-vs-parental.html page is loading…